Investors Meeting Presentation
for Q2 FY2022

ON November 1, 2022 Sumitomo Dainippon Pharma reported its second quarter results (Presentation, Sumitomo Dainippon Pharma, NOV 1, 2022, View Source [SID1234624427]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!